...
首页> 外文期刊>Cureus. >Coronavirus Disease 2019: A Comprehensive Review of Etiology, Pathogenesis, Diagnosis, and Ongoing Clinical Trials
【24h】

Coronavirus Disease 2019: A Comprehensive Review of Etiology, Pathogenesis, Diagnosis, and Ongoing Clinical Trials

机译:2019年冠状病毒疾病:全面审查病因,发病机制,诊断和持续的临床试验

获取原文
           

摘要

Coronavirus disease 2019 (COVID-19) is an acute respiratory viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease outbreak started in China in late December 2019 and quickly spread to the rest of the world, resulting in a pandemic. The incidence of cases is increasing every day, affecting millions of people around the globe and resulting in a public health emergency. Furthermore, disease management has been challenging for the clinicians and other medical personnel in terms of treatment options and availability of personal protective equipment. The off-label use of drugs such as hydroxychloroquine and emergency use authorization of remdesivir can hopefully help the clinicians while treating critically ill patients. The use of convalescent serum has also shown some interim benefit until a definitive treatment and preventive options are uncovered, such as vaccines and other effective treatment regimens.
机译:冠状病毒疾病2019(Covid-19)是由严重急性呼吸综合征冠状病毒2(SARS-COV-2)引起的急性呼吸道病毒感染。 2019年12月下旬在中国开始疾病爆发,迅速蔓延到世界其他地区,导致大流行。案件的发生率每天都在增加,影响全球数百万人,并导致公共卫生紧急情况。此外,在治疗方面和个人防护装备的可用性方面,疾病管理对临床医生和其他医务人员来说一直在挑战。亚羟氯喹和紧急用途授权等药物的偏离标签使用可以帮助临床医生,同时治疗危重病人。在发现过定的治疗和预防选择,例如疫苗和其他有效治疗方案,也显示出一些临时效益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号